EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition)

Juxian Sun, Yong Xia, Feng Shen, Shuqun Cheng

Hepatobiliary Surgery and Nutrition · 2025-04 · 14 (2) · 246-266

DOI: 10.21037/hbsn-24-359 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hepatobiliary Surgery and Nutrition, 2025-04. Verfasst von Juxian Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Surgical resection is the preferred treatment for HCC, but the postoperative recurrence and metastasis rates are high. Current evidence shows that microvascular invasion (MVI) is an independent risk factor for postoperative recurrence and metastasis, but there are still many controversies about the diagnosis, classification, prediction, and treatment of MVI worldwide.

Methods

Systematic literature reviews to identify knowledge gaps and support consensus statements and a modified Delphi method to develop evidence- and expert-based guidelines and finalization of the clinical consensus statements based on recommendations from a panel of experts.

Results

After many discussions and revisions, the Chinese Association of Liver Cancer of the Chinese Medical Doctor Association organized domestic experts in related fields to form the "Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition)" which included eight recommendations to better guide the prediction, diagnosis and treatment of HCC patients with MVI. The MVI pathological grading criteria as outlined in the "Guidelines for Pathological Diagnosis of Primary Liver Cancer" and the Eastern Hepatobiliary Surgery Hospital (EHBH) nomogram for predicting MVI are highly recommended.

Conclusions

We present an expert consensus on the diagnosis and treatment of MVI and potentially improve recurrence-free survival (RFS) and overall survival (OS) for HCC patients with MVI.

Schlagwörter

Stichwörter der Autor:innen

Hepatocellular carcinoma (HCC)consensusmicrovascular invasion (MVI)

Autor:innen und Institutionen

  • Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
  • Department of Hepatic Surgery IV, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.

Zitieren

APA

Sun, J., Xia, Y., Shen, F., & Cheng, S. (2025). Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition). Hepatobiliary Surgery and Nutrition, 14(2), 246-266. https://doi.org/10.21037/hbsn-24-359

Vancouver

Sun J, Xia Y, Shen F, Cheng S. Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition). Hepatobiliary Surgery and Nutrition. 2025;14(2):246-266. doi:10.21037/hbsn-24-359

BibTeX
@article{Sun2025,
  author = {Sun, Juxian and Xia, Yong and Shen, Feng and Cheng, Shuqun},
  title = {Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition)},
  journal = {Hepatobiliary Surgery and Nutrition},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {246--266},
  doi = {10.21037/hbsn-24-359}
}
Kostenlos starten →